✦ LIBER ✦

Who should receive fibric acid derivatives?

Book ID: 120857667
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414280-00008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fibric acid derivatives/rosiglitazone

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Metabolism of Fibric Acid Derivatives

✍ J. David Spence 📂 Article 📅 1998 🏛 Springer International Publishing AG 🌐 English ⚖ 69 KB

Who should receive methadone maintenance

Who should receive methadone maintenance?

✍ JAMES BELL; EROL DIGIUSTO; KAREN BYTH 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

Who should receive influenza vaccine?

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 186 KB

Lipid profiles on fibric-acid derivative

Lipid profiles on fibric-acid derivatives

✍ NigelE. Capps 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 326 KB

Who should receive hormone replacement t

Who should receive hormone replacement therapy?

✍ Francine K. Welty 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 1004 KB

Coronary heart disease is the leading cause of death in women in the United States and increases dramatically in postmenopausal women. The following review summarizes the known benefits and risks of hormone replacement therapy and gives recommendations for use of hormone replacement in women. Estrog